Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory.

Artusa, Valentina; Calabrone, Luana; Mortara, Lorenzo; Peri, Francesco; Bruno, Antonino

Artusa, Valentina; Calabrone, Luana; Mortara, Lorenzo; Peri, Francesco; Bruno, Antonino.

Afiliação

Artusa V; Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry and Immunology, IRCCS MultiMedica, 20138 Milan, Italy.
Calabrone L; Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry and Immunology, IRCCS MultiMedica, 20138 Milan, Italy.
Mortara L; Immunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
Peri F; Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy.
Bruno A; Laboratory of Innate Immunity, Unit of Molecular Pathology, Biochemistry and Immunology, IRCCS MultiMedica, 20138 Milan, Italy.

Int J Mol Sci ; 24(5)2023 Mar 05.

Article em En | MEDLINE | ID: mdl-36902427

Assuntos

Produtos Biológicos; Microbiota; Neoplasias; Humanos; Resistencia a Medicamentos Antineoplásicos; Produtos Biológicos/farmacologia; Neoplasias/patologia; Células-Tronco Neoplásicas/metabolismo

Palavras-chave

bioactive compounds; cancer stem cells (CSCs); drug resistance; gut microbiota; microbiota-derived metabolites; natural products

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Microbiota / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google